Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,230 public trials 3,233 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Active, Not Recruiting

Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)

NCT06048133

Conditions
Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
Locations
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Michigan Health System Ann Arbor, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

AZD0901 Compared With Investigator's Choice of Therapy in Participants With Second- or Later-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Claudin18.2

NCT06346392

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Research Site Mobile, Alabama, United States
  • Research Site Tucson, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Irvine, California, United States
View all 158 locations
View Trial Details
Active, Not Recruiting

Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

NCT04291105

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colo-rectal Cancer, +25 more
Locations
  • Saint John's Health Center - John Wayne Cancer Institute (JWCI) Santa Monica, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
  • Ochsner Clinic Foundation New Orleans, Louisiana, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study to Determine Whether Chemotherapy and Atezolizumab is Better Than Chemotherapy, Bevacizumab and Atezolizumab in Patients With Advanced Liver Cancer

NCT05211323

Conditions
Combined Hepatocellular Carcinoma and Cholangiocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +6 more
Locations
  • Sutter Auburn Faith Hospital Auburn, California, United States
  • Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
  • Palo Alto Medical Foundation-Fremont Fremont, California, United States
  • Memorial Medical Center Modesto, California, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of Nivolumab to Standard Treatment for Patients With Metastatic or Unresectable Colorectal Cancer That Have a BRAF Mutation

NCT05308446

Conditions
Colonic Diseases, Colonic Neoplasms, Colorectal Neoplasms, +18 more
Locations
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
  • Mercy Cancer Center - Carmichael Carmichael, California, United States
  • Mercy San Juan Medical Center Carmichael, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
View all 286 locations
View Trial Details
Active, Not Recruiting

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

NCT06147037

Conditions
Adenocarcinoma, Advanced Solid Tumor, Bronchial Neoplasms, +42 more
Locations
  • Research Site Palo Alto, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Omaha, Nebraska, United States
  • Research Site Cleveland, Ohio, United States
View Trial Details

Related conditions